Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „Prezista“
Suchtreffer
Begriffe & Kennungen
Prezista · 4.5 · A clinical study utilising a cocktail of medicinal products that are metabolised by cytochromes CYP2C9, CYP2C1
Eintrag öffnenPrezista · 4.5 · A clinical study utilising a cocktail of medicinal products that are metabolised by cytochromes CYP2C9, CYP2C1
Eintrag öffnenPrezista · 4.5 · Although the effect on CYP2C8 has only been studied in vitro, co-administration of darunavir and ritonavir and
Eintrag öffnenPrezista · 4.5 · Although the effect on CYP2C8 has only been studied in vitro, co-administration of darunavir and ritonavir and
Eintrag öffnenPrezista · 4.5 · Amiodarone Co-administration of boosted Bepridil PREZISTA and amiodarone, Dronedarone bepridil, dronedarone, i
Eintrag öffnenPrezista · 4.5 · Amiodarone Co-administration of boosted Bepridil PREZISTA and amiodarone, Dronedarone bepridil, dronedarone, i
Eintrag öffnenPrezista · 4.5 · Amiodarone PREZISTA co-administered with Bepridil low dose ritonavir and Dronedarone amiodarone, bepridil, dro
Eintrag öffnenPrezista · 4.5 · Atazanavir: comparison of atazanavir/ritonavir 300/100 mg once daily vs. atazanavir 300 mg once daily in combi
Eintrag öffnenPrezista · 4.5 · Clopidogrel Not studied. Co-administration of Co-administration of clopidogrel clopidogrel with boosted PREZIS
Eintrag öffnenPrezista · 4.5 · Clotrimazole Not Studied. Concomitant systemic use of clotrimazole and boosted PREZISTA may increase plasma co
Eintrag öffnenPrezista · 4.5 · Clotrimazole Not studied. Concomitant systemic use of clotrimazole and boosted PREZISTA may increase plasma co
Eintrag öffnenPrezista · 4.5 · Clotrimazole Not studied. Concomitant systemic use of clotrimazole and darunavir co-administered with low dose
Eintrag öffnenPrezista · 4.5 · Co-administration of boosted darunavir with drugs that have active metabolite(s) formed by CYP3A may result in
Eintrag öffnenPrezista · 4.5 · Co-administration of boosted darunavir with drugs that have active metabolite(s) formed by CYP3A may result in
Eintrag öffnenPrezista · 4.5 · Co-administration of darunavir and ritonavir with other medicinal products that inhibit CYP3A may decrease the
Eintrag öffnenPrezista · 4.5 · Co-administration of darunavir and ritonavir with other medicinal products that inhibit CYP3A may decrease the
Eintrag öffnenPrezista · 4.5 · Co-administration of darunavir/ritonavir with drugs that have active metabolite(s) formed by CYP3A may result
Eintrag öffnenPrezista · 4.5 · Co-administration with PREZISTA co-administered with cobicistat is not recommended (see section 4.4).
Eintrag öffnenPrezista · 4.5 · Co-administration with PREZISTA co-administered with cobicistat is not recommended (see section 4.4). Etraviri
Eintrag öffnenPrezista · 4.5 · Concomitant use of PREZISTA Clinical monitoring is co-administered with low dose ritonavir recommended when an
Eintrag öffnen